Author:
Isabirye Alone,Elwange Bob Charlestine,Singh Kavita,De Allegri Manuela
Abstract
Abstract
Background
Despite the benefits of cervical cancer (CC) screening to reduce the disease burden, uptake remains limited in developing countries. This study aims to assess the individual and community-level determinants of cervical cancer screening among women of reproductive age in Zimbabwe.
Methods
We analyzed data collected from 400 communities from the 2015 Zimbabwe Demographic and Health Survey with a sample size of 9955 women aged 15–49 years. The descriptive statistics and multi-level regression models adjusted for potential covariates were performed to examine the association between individual, household and community-level factors and the uptake of cervical cancer screening in women.
Results
The mean (SD) age of women in Zimbabwe using cervical cancer screening was 27.9 (9.9) years. A relatively small proportion of women, i.e., only 13.4% had ever screened for cervical cancer, with higher screening rates observed in the following sub-groups: middle aged women 31–49 years (odds ratio (OR) = 2.01; 95% confidence intervals (CI) 1.72–2.34), and currently working (OR = 1.35; 95% CI 1.17–1.55), those with health insurance (OR = 1.95; 95% CI 1.63–2.34), used modern contraceptives (OR = 1.51; 95% CI 1.22–1.86), exposed to multiple media (OR = 1.27; 95% CI 1.03–1.58), those living in communities that had a high predominance of women with favorable attitude towards Intimate Partner Violence (IPV) against women (OR = 1.21; 95% CI 1.04–1.41) and a non-poor wealth index (OR = 1.54; 95% CI 1.14–2.05).
Conclusions
Our data shows a significantly low prevalence of cervical cancer screening among reproductive age women in Zimbabwe. To increase the uptake of cervical cancer screening, there is an urgent need both to implement behavioral interventions targeted at women from low socio-economic groups and to advocate for universal health coverage that includes financial risk protection to help all women realize their right to health.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Reproductive Medicine,General Medicine
Reference61 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LAJA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;00(00):1–31. https://doi.org/10.3322/caac.21492.
2. Castanon A, Landy R, Pesola F, Windridge P, Sasieni P. Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study. Lancet Public Heal. 2018;3:34–43. https://doi.org/10.1016/S2468-2667(17)30222-0.
3. Wild CP, Weiderpass E, Stewart BW. World Cancer Report: Cancer Research for Cancer Prevention. International Agency for Research on Cancer; 2020. http://publications.iarc.fr/586
4. Chokunonga E, Borok MZ, Chirenje MZ, Makunike-Mutasa R, Ndlovhu N, Nyakabau AM, Vuma S. Pattern of Cancer in Zimbabwe in 2015, Zimbabwe National Cancer Registry (ZNCR); 2017. https://www.globalgiving.org/pfil/40777/projdoc.pdf
5. Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. Human Papillomavirus and Related Diseases in Africa: Summary Report 17 June 2019: ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre); 2019.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献